Colorectal mucinous adenocarcinoma (CMA) is a histologically and molecularly distinct subtype of colorectal cancer (CRC), marked by abundant extracellular mucin, a predilection for the proximal colon, and frequent overlap with deficient mismatch repair/high microsatellite instability (dMMR/MSI-H), BRAF V600E mutation,...
Wei Yu, Sheng-Tian Wei, Shi-Qing Wan et al.· Frontiers in Pharmacology· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid malignancies, with a dismal prognosis and a 5-year overall survival rate of 5–10%. Owing to the absence of specific symptoms at early stages, the majority of patients are first diagnosed with already locally advanced or metastatic disease. Cons...